why choose us

Clinical Trials Search

Showing 16,740 of 132,963 result(s)
Octreotide Improves Human Lymphatic Fluid Transport a Translational Trial

Status: Completed

Condition: Lymphatic Diseases
Chylothorax

Interventions: Interventional

Date: 2023-01-04

Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors

Status: Active, not recruiting

Condition: SARS-CoV-2 Infection
Hematologic Malignancy

Interventions: Other: None intervention
None intervention.

Date: 2023-01-04

Application of Intraoperative Transesophageal Echocardiography Imaging of Vein and CLCVP in Early Prediction and Intervention CSA-AKI

Status: Completed

Condition: Acute Kidney Injury

Interventions: Application of Intraoperative Transesophageal Echocardiography Imaging of Vein and CLCVP in Early Prediction and Intervention CSA-AKI

Date: 2023-01-04

Study of Music Therapy in Pain Rehabilitation Programs

Status: Active, not recruiting

Condition: Music Therapy

Interventions: Interventional

Date: 2023-01-04

Anatomical Resection in Colorectal Liver Metastases Patients

Status: Completed

Condition: The Characteristics of CRLM Patients Who Would Benefit More From Anatomical Resection

Interventions: Procedure: Anatomical Resection
Based upon the segmental anatomy of the liver according to Couinaud system, AR was defined as resection of 1 or m

Date: 2023-01-04

A Technological Approach to Improved Breastfeeding Rates and Self-Efficacy

Status: Completed

Condition: Breastfeeding

Interventions: Interventional

Date: 2023-01-04

Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)

Status: ACTIVE_NOT_RECRUITING

Condition: ADHD

Interventions: NRCT-101SR is a sustained release formulation.
Subjects ? 50 kg LBM receive a total of four 500 mg tablets;day and subjects < 50kg LBM re

Date: 2023-01-04

Combined Neuromodulation and Cognitive Training for Post-mTBI Depression

Status: Completed

Condition: Depression

Interventions: iTBS over the left dorsolateral prefrontal cortex

Date: 2023-01-04

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

Status: Completed

Condition: Coronary Artery Disease

Interventions: After at least 30 days of DAPT [with aspirin 81-mg od and a potent P2Y12 inhibitor (prasugrel 10 mg od or ticagrelor 90-mg BID)] in chronic coronary s

Date: 2023-01-04